Clinical Trials Sponsored by SynerGene Therapeutics, Inc
Total 2994 results
-
Zai Lab (Shanghai) Co., Ltd.Mirati Therapeutics Inc.Active, not recruitingAdvanced or Metastatic Solid TumorChina
-
University of Southern CaliforniaNational Cancer Institute (NCI); Vasgene Therapeutics, Inc; Whittier FoundationTerminatedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Philadelphia Chromosome Positive | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia and other conditionsUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science University; Helsinn Therapeutics (U.S.), IncCompleted
-
Peloton Therapeutics, Inc., a subsidiary of Merck...National Institutes of Health (NIH)CompletedClear Cell Renal Cell Carcinoma | Von Hippel-Lindau Disease | Clear Cell RCC | ccRCC | VHL Gene Mutation | VHL Syndrome | VHL Gene Inactivation | VHL | Von Hippel | Von Hippel's Disease | Von Hippel-Lindau Syndrome, Modifiers ofUnited States
-
Washington University School of MedicineUnited States Department of Defense; Aclaris Therapeutics, Inc.Not yet recruitingHormone Receptor Positive HER-2 Negative Metastatic Breast CancerUnited States
-
Ryan Gentzler, MDMirati Therapeutics Inc.; University of VirginiaRecruitingAdagrasib + SRS for Patients With Metastatic KRAS G12C-mutated NSCLC With Untreated Brain MetastasesNSCLC | Non Small Cell Lung Cancer | KRAS G12CUnited States
-
AIM Vaccine Co., Ltd.Ningbo Rongan Biological Pharmaceutical Co. Ltd.; LiveRNA Therapeutics Inc.Recruiting
-
AIM Vaccine Co., Ltd.Ningbo Rongan Biological Pharmaceutical Co. Ltd.; LiveRNA Therapeutics Inc.Not yet recruiting
-
Memorial Sloan Kettering Cancer CenterJuno Therapeutics, Inc., a Bristol-Myers Squibb CompanyActive, not recruitingChronic Lymphocytic Leukemia (CLL) | Refractory | RelapsedUnited States
-
Memorial Sloan Kettering Cancer CenterJuno Therapeutics, Inc., a Bristol-Myers Squibb CompanyActive, not recruitingMultiple MyelomaUnited States
-
Jennifer Lee Caswell-JinNational Cancer Institute (NCI); QED Therapeutics, Inc.TerminatedBreast Cancer | HER2-negative Breast Cancer | ER Positive Breast Cancer | PR-Positive Breast CancerUnited States
-
Seoul National University Bundang HospitalKorea University Guro Hospital; S-Alpha Therapeutics, Inc.CompletedAllergy and ImmunologyKorea, Republic of
-
Clarus Therapeutics, Inc.Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterCompletedHypogonadismUnited States
-
Kartos Therapeutics, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups...RecruitingEndometrial CancerUnited States, Austria, Spain, Israel, Denmark, Sweden, Slovenia, Finland, Georgia, Italy, Romania, Poland, Canada, Estonia, Hungary, Lithuania, Norway
-
Colin D. Weekes, M.D., PhDActuate Therapeutics Inc.; Lustgarten FoundationRecruitingPancreatic Adenocarcinoma | Pancreatic Adenocarcinoma MetastaticUnited States
-
St. Jude Children's Research HospitalAbbVie; Gateway for Cancer Research; Karyopharm Therapeutics IncRecruitingRefractory Acute Myeloid Leukemia | Acute Myeloid Leukemia, in Relapse | Acute Leukemia of Ambiguous Lineage in Relapse | Refractory Acute Leukemia of Ambiguous LineageUnited States
-
Mamta ParikhNational Cancer Institute (NCI); Karyopharm Therapeutics IncRecruitingMetastatic Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma | Advanced Urothelial Carcinoma | Refractory Urothelial CarcinomaUnited States
-
Dana-Farber Cancer InstituteKaryopharm Therapeutics Inc; William Lawrence and Blanche Hughes FoundationActive, not recruitingRelapsed Acute Lymphoblastic Leukemia (ALL) | Refractory Acute Lymphoblastic Leukemia (ALL) | Relapsed Acute Myelogenous Leukemia (AML) | Refractory Acute Myelogenous Leukemia (AML) | Relapsed Mixed Lineage Leukemia | Refractory Mixed Lineage Leukemia | Relapsed Biphenotypic Leukemia | Refractory... and other conditionsUnited States
-
Jennifer R. Brown, MD, PhDAstraZeneca; TG Therapeutics, Inc.Active, not recruitingChronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Relapsed Chronic Lymphocytic LeukemiaUnited States
-
Canadian Medical and Surgical Knowledge Translation...HLS Therapeutics, Inc; Amarin CorporationCompletedCOVID-19 | Inflammatory ResponseCanada
-
Clarus Therapeutics, Inc.Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterCompletedHypogonadismUnited States
-
Shanghai General Hospital, Shanghai Jiao Tong University...Eyecure Therapeutics Inc.UnknownDegenerative Myopia With Macular Hole
-
INSYS Therapeutics IncPediatric Brain Tumor Consortium (PBTC), St. Jude Children's Research HospitalWithdrawnRecurrent Malignant GliomaUnited States
-
Synvista Therapeutics, IncNational Institutes of Health (NIH); National Heart and Lung InstituteCompletedCardiovascular DiseaseUnited States
-
Merus N.V.Chiltern International Inc.; Q2 Solutions; Oncology Therapeutic Development (OTD) and other collaboratorsRecruitingGastric Cancer | Colorectal Cancer | NSCLC | Head and Neck Squamous Cell Carcinoma | HNSCC | Advanced/Metastatic Solid Tumors | Gastroesophageal-junction CancerUnited States, Spain, Belgium, France, Netherlands, United Kingdom
-
China Medical University HospitalUniversity of South Florida; Buddhist Tzu Chi General Hospital; StemCyte, Inc.; Saneron CCEL Therapeutics, Inc...RecruitingPhase I Clinical Safety Study About Human Umbilical Cord Blood Monocyte in the Acute Ischemic StrokeAcute Ischemic StrokeTaiwan
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); AstraZeneca; Juno Therapeutics, Inc.; MedImmune...TerminatedRecurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedUnited States
-
Therapeutic Advances in Childhood Leukemia ConsortiumGlaxoSmithKline; NovartisTerminatedRelapsed T-Cell Acute Lymphoblastic Leukemia | Relapsed T-Cell Lymphoblastic LymphomaUnited States, France, Canada, Australia, Austria, Italy, Netherlands
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Bristol-Myers Squibb Services Unlimited CompanyRecruitingSystemic Lupus Erythematosus | Systemic Sclerosis | Idiopathic Inflammatory MyopathyUnited States, Belgium, France, Spain, Germany, Italy
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; Mirati Therapeutics Inc.RecruitingResectable Non-Small Cell Lung CancerUnited States
-
Ida Bruun KristensenOdense Patient Data Explorative Network; Karyopharm Therapeutics IncActive, not recruitingMultiple MyelomaDenmark, Norway, Estonia
-
Nohla Therapeutics, Inc.National Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedMyelodysplastic Syndrome | Chronic Myelogenous Leukemia | Acute Biphenotypic Leukemia | Acute Myeloid Leukemia in Remission | Acute Lymphoblastic Leukemia in RemissionUnited States
-
Etan OrgelTherapeutic Advances in Childhood Leukemia ConsortiumRecruitingObesity | B-cell Acute Lymphoblastic LeukemiaUnited States
-
University of Colorado, DenverNational Institute on Aging (NIA); Alzheimer's Association; Partner Therapeutics...RecruitingPhase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease (SESAD)Alzheimer DiseaseUnited States
-
Aevi Genomic Medicine, LLC, a Cerecor companyMedgenics Medical Israel Ltd.Terminated
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Columbia University; Karyopharm Therapeutics IncCompletedMyelodysplastic SyndromesUnited States
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; Onyx Therapeutics, Inc.Completed
-
Providence Health & ServicesProvidence Cancer Center, Earle A. Chiles Research Institute; Galectin Therapeutics...CompletedMetastatic MelanomaUnited States
-
Clarus Therapeutics, Inc.Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; PharmaN...CompletedMale HypogonadismUnited States, Germany
-
Jett Foundation, Inc.Pfizer; Hoffmann-La Roche; Italfarmaco; Nationwide Children's Hospital; Capricor... and other collaboratorsCompletedDuchenne Muscular Dystrophy | Rare Diseases | Disability Physical | Burden, Dependency | Impairment | Disease ManagementUnited States
-
Translational Research in OncologyStand Up To Cancer; Effector TherapeuticsCompleted
-
NS Pharma, Inc.Cooperative International Neuromuscular Research Group; Nippon Shinyaku Co.... and other collaboratorsCompletedDuchenne Muscular DystrophyUnited States, Canada
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA); Yale University; Clinilabs, Inc.; BioXcel... and other collaboratorsRecruitingOpioid Use Disorder | Opioid WithdrawalUnited States
-
Multiple Myeloma Research ConsortiumEli Lilly and Company; GlaxoSmithKline; AbbVie; Takeda; Genentech, Inc.; Celgene Corporation and other collaboratorsRecruitingRelapsed Refractory Multiple MyelomaUnited States
-
Joshua ZeidnerUniversity of North Carolina, Chapel Hill; Stemline Therapeutics, Inc.RecruitingAcute Myeloid LeukemiaUnited States
-
Dana-Farber Cancer InstituteCookies for Kids' Cancer; Aileron Therapeutics, Inc.; TeamConnor Childhood Cancer...CompletedLymphoma | Leukemia | Solid Tumor | Brain TumorUnited States
-
NeuroEM Therapeutics, Inc.Axiom Clinical Research of Florida; MegaNano Biotech; Invicro, Boston; Left Coast...UnknownAlzheimer's DiseaseUnited States
-
European Organisation for Research and Treatment...Hoffmann-La Roche; Leap Therapeutics, Inc.WithdrawnEsophageal Cancer | Hepatobiliary Neoplasm | Biliary Tract Cancer | GastroEsophageal Cancer
-
NovaDigm Therapeutics, Inc.Uniformed Services University of the Health Sciences; Infectious Diseases Clinical...CompletedStaphylococcus AureusUnited States
-
Pear Therapeutics, Inc.National Institute on Drug Abuse (NIDA); Research Foundation for Mental Hygiene... and other collaboratorsCompletedOpioid-use DisorderUnited States